Embla Medical hf.
OSSFF
$4.15
$0.071.72%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 71.98% | -33.21% | -16.73% | 9.59% | 141.51% |
| Total Depreciation and Amortization | 17.66% | -2.83% | -6.24% | 0.81% | 1.61% |
| Total Amortization of Deferred Charges | -- | -1.71% | -- | -- | -- |
| Total Other Non-Cash Items | 267.50% | -85.66% | 3,506.87% | -109.57% | 141.12% |
| Change in Net Operating Assets | -20.91% | -384.66% | -21.73% | 189.26% | 54.10% |
| Cash from Operations | 60.73% | -67.08% | 0.86% | 46.04% | 605.35% |
| Capital Expenditure | -177.15% | 24.62% | 44.71% | 18.69% | 5.20% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 68.51% | -139.10% | 833.10% | 56.49% | 96.52% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 182.35% | -437.37% | 1,914.29% | -167.54% | 976.92% |
| Cash from Investing | 36.75% | -343.18% | 147.59% | 24.76% | 84.48% |
| Total Debt Issued | 563.40% | 140.16% | -- | -- | -- |
| Total Debt Repaid | -973.99% | -2.01% | 78.69% | -96.28% | -158.64% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -135.24% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1,609.70% | 102.57% | -26.73% | -96.28% | -117.15% |
| Foreign Exchange rate Adjustments | -13.33% | 159.83% | -290.18% | 1,938.14% | 92.01% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -58.16% | 13.09% | 24.17% | 2,872.92% | -103.06% |